E van der Ryst

Publication Activity (10 Years)

Years Active: 2021-2021
Publications (10 Years): 2

Top Topics

Regulatory T Cells

Top Venues

Antiviral chemistry & chemotherapy

This page only lists publications with an associated author ORCID identifier.

Publications

M E Lewis, B Jubb, P Simpson, A Lopatukhin, D Kireev, M Bobkova, Charles Craig, E van der Ryst, M Westby, S L Butler
Highly prevalent Russian HIV-1 V3-loop sequence variants are susceptible to maraviroc. Antiviral chemistry & chemotherapy 29 (2021)
M E Lewis, P Simpson, J Mori, B Jubb, J Sullivan, L McFadyen, E van der Ryst, Charles Craig, D L Robertson, M Westby
V3-Loop genotypes do not predict maraviroc susceptibility of CCR5-tropic virus or clinical response through week 48 in HIV-1-infected, treatment-experienced persons receiving optimized background regimens. Antiviral chemistry & chemotherapy 29 (2021)